datetime,headline,summary,related,lang,source
2020-12-07 16:15:00-05:00,"Installed Building Products Announces the Acquisition of Custom Glass & Doors, Inc.","COLUMBUS, Ohio--(BUSINESS WIRE)--Installed Building Products, Inc. (the “Company” or “IBP”) (NYSE: IBP), an industry-leading installer of insulation and complementary building products, announced today the acquisition of Custom Glass & Doors, Inc. (“CGD”). Founded in 1986, CGD is headquartered in Norcross, Georgia and primarily provides glass, shower, shelving, and mirror installation services to residential and multifamily customers. “With approximately $7.1 million of annual revenue, CGD",IBP,en,Business Wire
2020-11-20 02:40:41-05:00,Deutsche Bank Aktiengesellschaft Raises Installed Building Products (NYSE:IBP) Price Target to $114.00,"Installed Building Products (NYSE:IBP) had its price objective raised by Deutsche Bank Aktiengesellschaft from $110.00 to $114.00 in a report issued on Monday, The Fly reports. The firm currently has a buy rating on the construction company’s stock. A number of other research analysts also recently issued reports on the company. Benchmark downgraded Installed Building […]",IBP,en,Transcript Daily
2020-11-20 02:26:50-05:00,HC Wainwright Cuts Bio-Path (NASDAQ:BPTH) Price Target to $10.00,"Bio-Path (NASDAQ:BPTH) had its price objective reduced by HC Wainwright from $12.00 to $10.00 in a research note published on Monday, AnalystRatings.net reports. They currently have a buy rating on the stock. Separately, Zacks Investment Research downgraded Bio-Path from a buy rating to a hold rating in a research note on Monday, October 19th. Shares […]",IBP,en,Transcript Daily
2020-11-13 04:17:47-05:00,"Earnings Scheduled For November 13, 2020 - Stocks News Feed","Companies Reporting Before The Bell • Bio-Path Holdings (NASDAQ:BPTH) is expected to report earnings for its third quarter. • DraftKings (NASDAQ:DKNG) is expected to report quarterly loss at $0.61 per share on revenue of $131.75 million. • Digirad (NASDAQ:DRAD) is estimated to report quarterly earnings at $0.15 per share on revenue of $30.72 million. •… Read More »Earnings Scheduled For November 13, 2020",IBP,en,Stocks News Feed
2020-11-12 23:17:00-05:00,"Earnings Scheduled For November 13, 2020",Companies Reporting Before The Bell • Bio-Path Holdings (NASDAQ:BPTH) is expected to report earnings for its third quarter. • DraftKings …,IBP,en,Benzinga
2020-11-06 08:00:00-05:00,"Bio-Path Holdings to Announce Third Quarter 2020 Financial Results on November 13, 2020","HOUSTON, Nov. 06, 2020 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: BPTH), a biotechnology company leveraging its proprietary DNAbilize®…",IBP,en,GlobeNewswire
2020-10-26 15:10:00-05:00,"Installed Building Products Announces the Acquisition of Norkote, Inc.","COLUMBUS, Ohio--(BUSINESS WIRE)--Installed Building Products, Inc. (the “Company” or “IBP”) (NYSE: IBP), an industry-leading installer of insulation and complementary building products, announced today the acquisition of Norkote, Inc. (“Norkote”). Founded in 1952, Norkote is headquartered in Everett, Washington and installs specialty coatings for fire protection, insulation, and acoustics in commercial and industrial applications. “With approximately $10 million of annual revenue, Norkote expan",IBP,en,Business Wire
2020-10-24 23:54:49-05:00,Bio-Path (NASDAQ:BPTH) Trading Down 10.5%,"Bio-Path Holdings, Inc. (NASDAQ:BPTH) shares dropped 10.5% during trading on Friday . The company traded as low as $4.50 and last traded at $4.71. Approximately 1,635,579 shares were traded during mid-day trading, an increase of 348% from the average daily volume of 365,342 shares. The stock had previously closed at $5.26. BPTH has been the […]",IBP,en,The Lincolnian
2020-10-24 05:50:50-05:00,Bio-Path (NASDAQ:BPTH) Shares Gap Up to $4.09,"Shares of Bio-Path Holdings, Inc. (NASDAQ:BPTH) gapped up prior to trading on Thursday . The stock had previously closed at $4.09, but opened at $5.46. Bio-Path shares last traded at $5.07, with a volume of 853,328 shares changing hands. A number of equities research analysts have recently issued reports on the stock. HC Wainwright reaffirmed […]",IBP,en,Zolmax News
2020-10-23 23:12:47-05:00,"Insider Selling: Installed Building Products Inc (NYSE:IBP) Director Sells $3,898,025.56 in Stock","Installed Building Products Inc (NYSE:IBP) Director Vikas Verma sold 35,321 shares of the firm’s stock in a transaction on Tuesday, October 20th. The stock was sold at an average price of $110.36, for a total transaction of $3,898,025.56. Following the completion of the sale, the director now directly owns 36,200 shares in the company, valued […]",IBP,en,The Lincolnian
2020-10-23 13:30:42-05:00,Bio-Path (NASDAQ:BPTH) Stock Price Down 10.5%,"Shares of Bio-Path Holdings, Inc. (NASDAQ:BPTH) fell 10.5% during mid-day trading on Friday . The company traded as low as $4.50 and last traded at $4.71. 1,635,579 shares changed hands during trading, an increase of 348% from the average session volume of 365,342 shares. The stock had previously closed at $5.26. A number of research […]",IBP,en,US Banking News
2020-10-23 04:05:09-05:00,Bio-Path (NASDAQ:BPTH) Rating Lowered to Hold at Zacks Investment Research,"Zacks Investment Research downgraded shares of Bio-Path (NASDAQ:BPTH) from a buy rating to a hold rating in a report published on Monday morning, Zacks.com reports. According to Zacks, “BIO-PATH is developing leading-edge, patented, liposomal drug delivery systems, with two clinical cancer drug candidates ready for the clinic and a third siRNA cancer drug undergoing final […]",IBP,en,Transcript Daily
2020-10-22 20:32:41-05:00,"Vikas Verma Sells 35,321 Shares of Installed Building Products Inc (NYSE:IBP) Stock","Installed Building Products Inc (NYSE:IBP) Director Vikas Verma sold 35,321 shares of the stock in a transaction dated Tuesday, October 20th. The shares were sold at an average price of $110.36, for a total value of $3,898,025.56. Following the completion of the transaction, the director now directly owns 36,200 shares in the company, valued at […]",IBP,en,Daily Political
2020-10-22 06:35:12-05:00,Installed Building Products Inc (NYSE:IBP) Receives Consensus Recommendation of “Buy” from Brokerages,"Installed Building Products Inc (NYSE:IBP) has been assigned a consensus rating of “Buy” from the sixteen research firms that are currently covering the company, MarketBeat.com reports. Five equities research analysts have rated the stock with a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the company. […]",IBP,en, Dakota Financial News
2020-10-21 02:28:45-05:00,Bio-Path (NASDAQ:BPTH) Stock Rating Lowered by Zacks Investment Research,"Bio-Path (NASDAQ:BPTH) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a report issued on Monday, Zacks.com reports. According to Zacks, “BIO-PATH is developing leading-edge, patented, liposomal drug delivery systems, with two clinical cancer drug candidates ready for the clinic and a third siRNA cancer drug undergoing final pre-clinical […]",IBP,en,Zolmax News
2020-10-20 17:38:43-05:00,Installed Building Products Inc (NYSE:IBP) Expected to Post Quarterly Sales of $436.70 Million,"Wall Street analysts forecast that Installed Building Products Inc (NYSE:IBP) will announce $436.70 million in sales for the current quarter, according to Zacks. Four analysts have made estimates for Installed Building Products’ earnings. The highest sales estimate is $442.30 million and the lowest is $431.00 million. Installed Building Products posted sales of $396.45 million during […]",IBP,en,Daily Political
2020-10-20 11:56:47-05:00,Analysts Anticipate Bio-Path Holdings Inc (NASDAQ:BPTH) to Post -$0.83 Earnings Per Share,"Equities research analysts expect Bio-Path Holdings Inc (NASDAQ:BPTH) to post ($0.83) earnings per share for the current fiscal quarter, according to Zacks. Zero analysts have provided estimates for Bio-Path’s earnings. Bio-Path reported earnings of ($0.78) per share in the same quarter last year, which suggests a negative year-over-year growth rate of 6.4%. The firm is […]",IBP,en,Transcript Daily
2020-05-11 05:36:00-05:00,Installed Building's (IBP) Shares Up on Q1 Earnings Beat,Installed Building Products' (IBP) first-quarter 2020 results benefit from strong pricing and end-market demand.,IBP,en,Zacks Investment Research
2020-05-08 08:05:05-05:00,Installed Building Products (IBP) Q1 Earnings and Revenues Beat Estimates,"Installed Building Products (IBP) delivered earnings and revenue surprises of 25.81% and 4.11%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?",IBP,en,Zacks Investment Research
2020-05-08 06:00:00-05:00,Installed Building Products Reports Record Results for First Quarter 2020,"COLUMBUS, Ohio--(BUSINESS WIRE)--Installed Building Products, Inc. (the ""Company"" or ""IBP"") (NYSE: IBP), an industry-leading installer of insulation and complementary building products, today announced results for the first quarter ended March 31, 2020. First Quarter 2020 Highlights (Comparisons are to Prior Year Period) Net revenue increased 16.1% to a first quarter record of $397.3 million Net income increased 81.0% to $16.0 million Adjusted EBITDA* increased 37.9% to $49.2 million Net cash p",IBP,en,Business Wire
2020-04-24 11:10:11-05:00,Why the Earnings Surprise Streak Could Continue for Installed Building Products (IBP),Installed Building Products (IBP) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.,IBP,en,Zacks Investment Research
2020-03-13 06:52:53-05:00,"The Daily Biotech Pulse: Roche Obtains FDA Emergency Use Authorization For COVID-19 Test, Chembio Appoints New CEO, Inovio Slumps On Earnings","Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 12.) Masimo Corporation (NASDAQ: MASI ) Down In The Dumps (Biotech stocks that hit 52-week lows March 12.) Abbott Laboratories (NYSE: ABT ) ABIOMED, Inc. (NASDAQ: ABMD ) Acasti Pharma Inc (NASDAQ: ACST ) Accelerate Diagnostics Inc (NASDAQ: AXDX ) AcelRx Pharmaceuticals Inc (NASDAQ: ACRX ) Achieve Life Sciences Inc (NASDAQ: ACHV ) Acorda Therapeutics Inc (NASDAQ: ACOR ) Adamas Pharmaceuticals Inc (NASDAQ: ADMS ) Adamis Pharmaceuticals Corp (NASDAQ: ADM ) Adaptive Biotechnologies Corp (NASDAQ: ADPT ) ADDEX THERAPEUT/ADR (NASDAQ: ADXN ) ADMA Biologics Inc (NASDAQ: ADMA ) Aeglea Bio Therapeutics Inc (NASDAQ: AGLE ) Aerie Pharmaceuticals Inc (NASDAQ: AERI ) AEterna Zentaris Inc. (NASDAQ: AEZS ) Affimed NV (NASDAQ: AFMD ) Aileron Therapeutics Inc (NASDAQ: ALRN ) Aimmune Therapeutics Inc (NASDAQ: AIMT ) Akari Therapeutics PLC (NASDAQ: AKTX ) Akcea Therapeutics Inc (NASDAQ: AKCA ) Akero Therapeutics Inc (NASDAQ: AKRO ) Akers Biosciences Inc (NASDAQ: AKER ) Akorn, Inc.",IBP,en,Benzinga
2020-03-10 08:19:55-05:00,"The Daily Biotech Pulse: Mesoblast To Test Candidate On Coronavirus Symptoms, Proxy Battle Ahead For Rockwell Medical, Glaukos to Join S&P SmallCap 600 Index","Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 9.) Arcutis Biotherapeutics Inc (NASDAQ: ARQT ) Enzo Biochem, Inc. (NYSE: ENZ ) Centogene NV (NASDAQ: CNTG ) Inovio Pharmaceuticals Inc (NASDAQ: INO ) Spherix Inc (NASDAQ: SPEX ) ( added to Friday's advance on clinching an option agreement for coronavirus treatment) Down In The Dumps (Biotech stocks that hit 52-week lows March 9.) ABIOMED, Inc. (NASDAQ: ABMD ) Acasti Pharma Inc (NASDAQ: ACST ) Achieve Life Sciences Inc (NASDAQ: ACHV ) Acorda Therapeutics Inc (NASDAQ: ACOR ) Adamas Pharmaceuticals Inc (NASDAQ: ADMS ) Adaptive Biotechnologies Corp (NASDAQ: ADPT ) ADMA Biologics Inc (NASDAQ: ADMA ) Aeglea Bio Therapeutics Inc (NASDAQ: AGLE ) Aerie Pharmaceuticals Inc (NASDAQ: AERI ) AEterna Zentaris Inc. (NASDAQ: AEZS ) Affimed NV (NASDAQ: AFMD ) Akers Biosciences Inc (NASDAQ: AKER ) Akorn, Inc. (NASDAQ: AKRX ) Aldeyra Therapeutics Inc (NASDAQ: ALDX ) Alexion Pharmaceuticals, Inc.","IDRA,ICCC,IBP",en,Benzinga
2020-03-06 07:59:18-05:00,Bio-Path Holdings (NASDAQ: BPTH): 2019 Earnings Snapshot,"— Bio-Path Holdings Inc. (NASDAQ: BPTH) reported a loss of $3.24 share for the full year 2019, narrower than a loss of $14.38 per share…",IBP,en,news.alphastreet.com
2020-03-03 10:53:00-05:00,Installed Building (IBP) Buys Royals Commercial for Expansion,Installed Building Products' (IBP) acquisition strategy is set to boost its geographical boundaries and product offerings.,IBP,en,Zacks Investment Research
2020-02-20 17:50:10-05:00,Installed Building Products (IBP) Gains As Market Dips: What You Should Know,"In the latest trading session, Installed Building Products (IBP) closed at $77.88, marking a +0.78% move from the previous day.",IBP,en,Zacks Investment Research
2020-02-20 08:00:00-05:00,Installed Building Products to Report Fourth Quarter 2019 Financial Results,"Installed Building Products, Inc. (the “Company”) (NYSE: IBP), an industry-leading installer of insulation products, announced today that the Company",IBP,en,Business Wire
2020-02-12 17:50:17-05:00,Installed Building Products (IBP) Stock Sinks As Market Gains: What You Should Know,"Installed Building Products (IBP) closed at $74.52 in the latest trading session, marking a -1.68% move from the prior day.",IBP,en,Zacks Investment Research
2020-01-28 12:10:17-05:00,Will Installed Building Products (IBP) Beat Estimates Again in Its Next Earnings Report?,Installed Building Products (IBP) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.,IBP,en,Zacks Investment Research
2020-01-08 02:55:00-05:00,Why You Should Buy Installed Building Products Stock Now,"Installed Building Products' (IBP) higher pricing strategy, stable end-market demand and solid acquisition strategy are likely to help it grow further.",IBP,en,Zacks Investment Research
2019-12-18 07:00:00-05:00,Installed Building Products Foundation Exceeds $1 Million Goal,"COLUMBUS, Ohio--(BUSINESS WIRE)--Nine months after Installed Building Products, Inc. (NYSE: IBP), an industry-leading installer of insulation and building products, launched the Installed Building Products Foundation, the organization has exceeded its goal of donating $1 million to nonprofits and individuals. Since March, the IBP Foundation’s Major Grants program has awarded $825,000 to nonprofit organizations that provide home-building or renovation services for those in need. Those nonprofits",IBP,en,Business Wire
2019-12-17 10:41:37-05:00,"RBC Bullish On Installed Building Products, Downgrades 3 Other Homebuilders","Housing had a strong 2019, but not all players set a sturdy foundation. One analyst team sees growth for one building company and decay for three others. The Rating RBC Capital analysts led by Mike Dahl upgraded Installed Building Products Inc (NYSE: IBP ) to Outperform and raised their price target from $73 to $80. They downgraded: D. R. Horton Inc (NYSE: DHI ) to Underperform and cut their target from $52 to $52; Fortune Brands Home & Security Inc (NYSE: FBHS ) to Sector Perform but maintained a $67 target; and Lennar Corporation (NYSE: LEN ) to Sector Perform and cut their target from $63 to $62. The Homebuilder Thesis Homebuilders rallied strong throughout the year, and investor expectations continue to rise. But the analysts see little upside to the segment and suspects that optimism around D. R. Horton and Lennar are already baked into estimates. “We expect housing demand and order growth to remain solid in ’20, while pricing should improve modestly,” … Full story available on Benzinga.",IBP,en,Benzinga Feeds
2019-12-12 12:45:04-05:00,Installed Building Products (IBP) is an Incredible Growth Stock: 3 Reasons Why,"Installed Building Products (IBP) is well positioned to outperform the market, as it exhibits above-average growth in financials.",IBP,en,Zacks Investment Research
2019-12-05 07:45:00-05:00,Installed Building Products Announces Plans to Reprice Its Term Loan B Facility,"COLUMBUS, Ohio--(BUSINESS WIRE)--Installed Building Products, Inc. (the “Company”) (NYSE: IBP), an industry-leading installer of insulation products, announced today that the Company is seeking to reprice its existing $200 million Term Loan B facility. The terms of any repricing and any other changes to the existing facility will be disclosed upon the completion of the transaction, which is expected to be announced in the next several weeks. This proposed refinancing is subject to market and ot",IBP,en,Business Wire
2019-11-26 11:33:30-05:00,Bio-Path Holdings Completes Safety Testing Study in Stage 2 of Phase 2 Trial,The company announced it has completed the safety testing in the second stage of its Phase 2 clinical trial in acute myeloid leukemia. The post Bio-Path Holdings Completes Safety Testing Study in Stage 2 of Phase 2 Trial appeared first on Investing News Network .,IBP,en,Investing News Network
2019-11-21 18:30:36-05:00,Bio-Path’s Shares Dip on IND Application Approval,"The FDA has approved Bio-Path's IND for its second drug candidate, but the news sent the company's shares down over 30 percent. The post Bio-Path’s Shares Dip on IND Application Approval appeared first on Investing News Network .",IBP,en,Investing News Network
2019-11-21 11:38:44-05:00,Bio-Path Holdings Receives FDA Clearance for BP1002,A Phase 1 clinical trial will now evaluate BP1002's ability to treat refractory/relapsed lymphoma and chronic lymphocytic leukemia. The post Bio-Path Holdings Receives FDA Clearance for BP1002 appeared first on Investing News Network .,IBP,en,Investing News Network
2019-11-18 07:30:00-05:00,"Installed Building Products Announces Acquisition of Premier Building Supply, LLC.","COLUMBUS, Ohio--(BUSINESS WIRE)--Installed Building Products, Inc. (the “Company” or “IBP”) (NYSE: IBP), an industry-leading installer of insulation and complementary building products, announced today the acquisition of Premier Building Supply, LLC (“Premier”). Founded in 2009, Premier is headquartered outside of Provo, Utah with additional locations in Lindon and Salt Lake City. The company provides insulation and garage door installation services primarily for new residential customers. “Wit",IBP,en,Business Wire
2019-11-11 10:00:08-05:00,Are You Looking for a Top Momentum Pick? Why Installed Building Products (IBP) is a Great Choice,Does Installed Building Products (IBP) have what it takes to be a top stock pick for momentum investors? Let's find out.,IBP,en,Zacks Investment Research
2019-08-08 07:25:07-05:00,Installed Building Products (IBP) Q2 Earnings and Revenues Top Estimates,"Installed Building Products (IBP) delivered earnings and revenue surprises of 3.57% and 1.24%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?",IBP,en,Zacks Investment Research
2019-08-01 09:33:37-05:00,Installed Building Products (IBP) Reports Next Week: Wall Street Expects Earnings Growth,Installed Building Products (IBP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,IBP,en,Zacks Investment Research
2019-07-25 09:34:08-05:00,Installed Building Products (IBP) Earnings Expected to Grow: What to Know Ahead of Q2 Release,Installed Building Products (IBP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,IBP,en,Zacks Investment Research
2019-05-16 16:01:31-05:00,Trade War Fears Trigger Nomura Instinet's Downgrade Of Housing Stocks,"Nomura Instinet downgraded several companies dependent on housing market growth Thursday, citing U.S.-China trade uncertainty that could put a damper on consumer confidence and economic growth. The Analyst Michael Wood downgraded four building-related companies from Buy to Neutral: TopBuild Corp (NYSE: BLD ), with a target price lowered from $90 to $85; GMS Inc (NYSE: GMS ), with a target price lowered from $27 to $20; Installed Building Products Inc (NYSE: IBP ), with a target price lowered from $54 to $50; and Owens Corning (NYSE: OC ), with a target price lowered from $78 to $48. The Thesis It’s hard to pinpoint what effect escalating tariffs might have on housing, Wood said in the Thursday downgrade note. Yet ""given the large-ticket nature of home buying, demand can be postponed for years during periods of uncertainty or a soft … Full story available on Benzinga.com",IBP,en,Benzinga
2019-05-16 15:51:27-05:00,Bio-Path files for $125M mixed shelf; shares down 7% after hours,No summary available.,IBP,en,Seeking Alpha
2019-05-16 13:16:28-05:00,Installed Building Products downgraded to neutral from buy at Instinet,"This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news.",IBP,en,MarketWatch
2019-05-16 10:41:22-05:00,"Bio-Path Holdings, Inc. (BPTH) CEO Peter Nielsen on Q1 2019 Results - Earnings Call Transcript","Bio-Path Holdings, Inc. (NASDAQ:BPTH) Q1 2019 Earnings Conference Call May 16, 2019 08:30 AM ET Company Participants Peter Nielsen - President, Chief Executive",IBP,en,Seeking Alpha
2019-05-07 07:45:06-05:00,3 Reasons Why Installed Building Products (IBP) Is a Great Growth Stock,Installed Building Products (IBP) could produce exceptional returns because of its solid growth attributes.,IBP,en,Zacks Investment Research
2019-05-05 21:23:12-05:00,Installed Building Products (IBP) Q1 2019 Earnings Call Transcript,"IBP earnings call for the period ending March 31, 2019.",IBP,en,The Motley Fool
2019-05-03 13:53:24-05:00,"Installed Building Products, Inc. (IBP) CEO Jeff Edwards on Q1 2019 Results - Earnings Call Transcript",No summary available.,IBP,en,Seeking Alpha
2019-05-02 13:04:33-05:00,"Installed Building Products, Inc. 2019 Q1 - Results - Earnings Call Slides",No summary available.,IBP,en,Seeking Alpha
2019-05-02 08:25:17-05:00,Installed Building Products (IBP) Meets Q1 Earnings Estimates,"Installed Building Products (IBP) delivered earnings and revenue surprises of 0.00% and 1.84%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?",IBP,en,Zacks Investment Research
2019-05-02 06:05:45-05:00,"Installed Building Products EPS in-line, beats on revenue",No summary available.,IBP,en,Seeking Alpha
2019-04-25 09:34:32-05:00,Installed Building Products (IBP) to Report Q1 Results: Wall Street Expects Earnings Growth,Installed Building Products (IBP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,IBP,en,Zacks Investment Research
2019-04-15 10:02:17-05:00,Fibrocell Science leads healthcare gainers; Conatus Pharmaceuticals and Aphria among the losers,Gainers: Fibrocell Science (FCSC) +46%. Bio-Path Holdings (BPTH) +45%. Conformis (CFMS) +9%. Catalent (CTLT) +8%. electroCore (ECOR) +7%. Losers: Conatus P,IBP,en,Seeking Alpha
2019-04-15 07:31:32-05:00,Bio-Path up 37% premarket on withdrawal of stock offering,No summary available.,IBP,en,Seeking Alpha
2019-03-27 07:45:00-05:00,Medical Device Industry Revenues Should Outpace Healthcare Field,"PALM BEACH, Florida , March 27, 2019 /PRNewswire/ -- The U.S. markets are bullish on the future of the medical device markets. In addition to projections that postulate that: ""In 2024, the total medical technology revenue globally is expected be nearly $600 billion U.S. dollars."" and that the: ""… U.S. remains the largest medical device market in the world, with a market size of around $156 billion as well as representing about 40 percent of the global medical device market…"" ( https://www.selectusa.gov/medical-technology-industry-united-states ) The markets, Moody's in particular, are expecting this trend to continue. Recently an online journal focusing on the medical device industry seemed to echo this optimistic view of the industry publishing an article titled: ""Moody's: Outlook strong for medical devices in 2019. The article said: "" The medical device industry should see a stand-out year in 2019, according to a Moody's report on the industry, Medtech Dive reports. The financial services company predicts a positive outlook for medtech, with forecasted earnings before interest, tax, depreciation and amortization of between 4.5% and 5.5% for companies on an organic basis, according to the report.",IBP,en,Benzinga
2019-03-25 13:07:18-05:00,"Monday's ETF Movers: ITB, SOXX",In trading on Monday the iShares U S Home Construction ETF is outperforming other ETFs up about 1 9 on the day Components of that ETF showing particular strength include shares of KB Home up about 4 3 and shares of Installed Building Products up about 3 6 on the day,IBP,en,Nasdaq
2019-03-25 10:01:16-05:00,Curis leads healthcare gainers; Recro Pharma and Sorrento Therapeutics among losers,No summary available.,IBP,en,Seeking Alpha
2019-03-22 10:02:52-05:00,Seelos Therapeutics leads healthcare gainers; Conatus Pharmaceuticals and SELLAS Life Sciences Group among losers,No summary available.,IBP,en,Seeking Alpha
2019-03-21 10:02:39-05:00,Sorrento Therapeutics leads healthcare gainers; Biogen tops the losers,No summary available.,IBP,en,Seeking Alpha
2019-03-21 08:15:38-05:00,BIIB and CSIQ among premarket losers,No summary available.,IBP,en,Seeking Alpha
2019-03-21 06:59:49-05:00,Bio-Path down 13% premarket,No summary available.,IBP,en,Seeking Alpha
2019-03-20 10:04:00-05:00,Cytokinetics and Fibrocell Science among healthcare gainers; Pulmatrix leads the losers,No summary available.,IBP,en,Seeking Alpha
2019-03-20 09:14:05-05:00,"Bio-Path Holdings (BPTH) CEO, Peter Nielsen on Q 2018 Results - Earnings Call Transcript",No summary available.,IBP,en,Seeking Alpha
2019-03-20 05:30:00-05:00,"Bio-Path Holdings, Inc. to Host Earnings Call","NEW YORK, NY / ACCESSWIRE / March 20, 2019 / Bio-Path Holdings, Inc. (NASDAQ: BPTH ) will be discussing their earnings results in their 2018 Fourth Quarter Earnings to be held on March 20, 2019 at 8:30 …",IBP,en,Yahoo Finance
2019-03-18 14:45:45-05:00,Atossa Genetics: Expect More Near-Term Positive Catalysts After Continued FDA Approval For One Patient,No summary available.,IBP,en,Seeking Alpha
2019-03-15 15:01:00-05:00,"Bio-Path Holdings to Announce Fourth Quarter and Full Year 2018 Financial Results on March 20, 2019","HOUSTON, March 15, 2019 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: BPTH ) a biotechnology company leveraging its proprietary DNAbilize ® antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid cancer drugs, today announced that it will host a live conference call and audio webcast on Wednesday, March 20, 2019 at 8:30 a.m. ET to report financial results for the fourth quarter and full year ended December 31, 2018 and to provide a business overview. To access … Full story available on Benzinga.com",IBP,en,Benzinga
2019-03-12 10:03:43-05:00,Seelos Therapeutics and Bio-Path Holdings among healthcare gainers; NuVasive and Zafgen among the losers,No summary available.,IBP,en,Seeking Alpha
2019-03-12 08:28:03-05:00,Bio-Path launches stock offering; shares down 8% premarket,No summary available.,IBP,en,Seeking Alpha
2019-03-11 10:03:44-05:00,Seres Therapeutics and Tonix Pharmaceuticals among healthcare gainers; Quorum Health and Stellar Biotechnologies among the losers,No summary available.,IBP,en,Seeking Alpha
2019-03-08 11:06:31-05:00,TrovaGene leads healthcare gainers; CHF Solutions and Altimmune among the losers,No summary available.,IBP,en,Seeking Alpha
2019-03-08 09:22:07-05:00,Healthcare and Tech stocks among major premarket losers,No summary available.,IBP,en,Seeking Alpha
2019-03-07 12:17:36-05:00,Bio-Path up 174% on prexigebersen data,No summary available.,IBP,en,Seeking Alpha
2019-03-07 11:07:17-05:00,Seelos Therapeutics and Bio-Path Holdings among healthcare gainers; Aptevo Therapeutics leads the losers,No summary available.,IBP,en,Seeking Alpha
2019-03-06 11:06:16-05:00,22nd Century Group and Tenax Therapeutics among healthcare gainers; Ligand Pharmaceuticals and Endologix among the losers,No summary available.,IBP,en,Seeking Alpha
2019-03-06 08:40:23-05:00,Bio-Path up 54% premarket on positive prexigebersen data,No summary available.,IBP,en,Seeking Alpha
2019-03-05 11:03:21-05:00,Intrexon and DBV Technologies among healthcare gainers; Adamas Pharmaceuticals leads the losers,No summary available.,IBP,en,Seeking Alpha
2019-03-05 09:16:54-05:00,"AFH, HTZ and WB among premarket losers",No summary available.,IBP,en,Seeking Alpha
2019-03-04 09:08:43-05:00,EVOK and SE among premarket losers,No summary available.,IBP,en,Seeking Alpha
2019-03-02 03:42:06-05:00,"Installed Building Products, Inc. (IBP) CEO Jeffrey Edwards on Q4 2018 Results - Earnings Call Transcript",No summary available.,IBP,en,Seeking Alpha
2019-03-01 12:57:04-05:00,Healthcare and Tech dominate midday movers,No summary available.,IBP,en,Seeking Alpha
2019-03-01 11:00:56-05:00,Puma Biotechnology and Lexicon Pharmaceuticals among healthcare gainers; ImmunoGen leads the losers,No summary available.,IBP,en,Seeking Alpha
2019-03-01 10:51:03-05:00,Bio-Path up 132%,No summary available.,IBP,en,Seeking Alpha
2019-02-28 14:06:18-05:00,"Installed Building Products, Inc. 2018 Q4 - Results - Earnings Call Slides",No summary available.,IBP,en,Seeking Alpha
2019-02-28 07:07:03-05:00,"Installed Building Products beats by $0.09, beats on revenue",No summary available.,IBP,en,Seeking Alpha
2019-01-29 11:02:08-05:00,OncoCyte leads healthcare gainers; Allergan and Tilray among losers,No summary available.,IBP,en,Seeking Alpha
2019-01-23 11:04:36-05:00,Microbot Medical leads healthcare gainers; Rexahn Pharmaceuticals tops the losers,No summary available.,IBP,en,Seeking Alpha
2019-01-23 11:04:36-05:00,Microbot Medical leads healthcare gainers; Rexahn Pharmaceuticals tops the losers,No summary available.,IBP,en,Seeking Alpha
2019-01-18 08:25:04-05:00,Bio-Path reverse split shares 1:20,No summary available.,IBP,en,Seeking Alpha
2019-01-18 08:25:04-05:00,Bio-Path reverse split shares 1:20,No summary available.,IBP,en,Seeking Alpha
2019-01-17 16:12:07-05:00,Bio-Path closes $1.1M equity offering; shares up 5% after hours,No summary available.,IBP,en,Seeking Alpha
2019-01-17 16:12:07-05:00,Bio-Path closes $1.1M equity offering; shares up 5% after hours,No summary available.,IBP,en,Seeking Alpha
2019-01-17 16:12:07-05:00,Bio-Path $1.1M equity offering; shares up 5% after hours,No summary available.,IBP,en,Seeking Alpha
2019-01-17 16:12:07-05:00,Bio-Path $1.1M equity offering; shares up 5% after hours,No summary available.,IBP,en,Seeking Alpha
2019-01-15 05:52:32-05:00,Bio-Path Holdings prices $1.1M stock offering; shares down 35%,Bio-Path Holdings (BPTH) priced an underwritten public offering of 8.59M common shares at $0.13/share for gross proceeds of ~$1.1M. The offering is expecte,IBP,en,Seeking Alpha
2019-01-15 05:52:32-05:00,Bio-Path Holdings prices $1.1M stock offering; shares down 35%,Bio-Path Holdings (BPTH) priced an underwritten public offering of 8.59M common shares at $0.13/share for gross proceeds of ~$1.1M. The offering is expecte,IBP,en,Seeking Alpha
2019-01-14 16:08:29-05:00,Bio-Path readies stock offering; shares down 5% after hours,"Bio-Path Holdings (BPTH) is down 5% after hours in response to its announced stock offering. Price, volume and terms have yet to be announced.",IBP,en,Seeking Alpha
2019-01-14 16:08:29-05:00,Bio-Path readies stock offering; shares down 5% after hours,"Bio-Path Holdings (BPTH) is down 5% after hours in response to its announced stock offering. Price, volume and terms have yet to be announced.",IBP,en,Seeking Alpha
2019-01-04 13:11:19-05:00,"Biotechs lead broad market advance, XBI up 5%",No summary available.,"IBP,IBB",en,Seeking Alpha
